Palisade Bio Inc (PALI)

[BesaoT35]

Do investors in PALI still have any hope for NSI-189 in Alzheimer’s Disease which is shown to be safe and induces anatomically proven neurogenesis in human hippocampus?

The drug failed in phase 2 for Major Depression several years ago. Perhaps dementia treatment is where the drug belongs.

Being shown to be safe, is there any chance of a “Right to Try” of NSI-189 for patients who are experiencing a cognitive decline and have no real treatments other than the BIIB drug ,recently approved, which has shown a minimal clinical benefit in the phase 3 trials? The BIIB drug showed a 6% rate of worrisome brain inflammation. NSI-189 is already shown to be safe and did help patients clinically in cognitive tests, but did not help with their depression.

NSI-189 was developed when our company was called NeuralStem I think.

Thanks.